Nifty
:
10853.55
Sensex
:
36665.61
35.95 (0.33%)
184.52 (0.51%)
Nifty
Sensex
:
:
10853.55
36665.61
35.95 (0.33%)
184.52 (0.51%)

Ipca Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :
72/99

BSE: 524494 | NSE: IPCALAB

NSE BSE
930.15
17-Sep-2019
  • Open
  • High
  • Low
  • Previous Close
  •  942.00
  •  951.90
  •  925.00
  •  946.55
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  190280
  •  1777.42
  •  1046.00
  •  599.95

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 11,776.65
  • 22.58
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 11,959.30
  • 0.32%
  • 3.60

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 46.07%
  • 1.82%
  • 10.70%
  • FII
  • DII
  • Others
  • 0.03%
  • 22.25%
  • 19.13%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.59
  • 3.15
  • 5.14

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.39
  • 6.08
  • 11.23

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 8.08
  • 12.18
  • 34.18

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 26.93
  • 38.22
  • 36.79

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.70
  • 3.36
  • 3.16

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.68
  • 19.30
  • 18.24

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 19
Jun 18
Var%
Mar 19
Mar 18
Var%
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Net Sales
1,078.19
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
879.47
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
198.72
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
18.43%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
20.34
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
4.59
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
46.10
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
168.37
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
37.35
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
131.02
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
12.15%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
10.26
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Net Sales
-
3,745.69
3,257.76
3,156.19
2,867.11
3,144.40
3,281.77
2,805.94
2,355.96
1,897.88
1,595.24
Net Sales Growth
-
14.98%
3.22%
10.08%
-8.82%
-4.19%
16.96%
19.10%
24.14%
18.97%
 
Cost Of Goods Sold
-
1,090.34
978.34
939.40
903.04
968.00
963.06
955.10
800.91
680.51
571.62
Gross Profit
-
2,655.35
2,279.42
2,216.79
1,964.07
2,176.40
2,318.71
1,850.84
1,555.05
1,217.37
1,023.62
GP Margin
-
70.89%
69.97%
70.24%
68.50%
69.22%
70.65%
65.96%
66.00%
64.14%
64.17%
Total Expenditure
-
3,067.42
2,815.78
2,740.77
2,593.42
2,630.33
2,569.79
2,268.34
1,928.47
1,558.05
1,293.16
Power & Fuel Cost
-
176.50
161.92
151.00
141.67
135.94
127.91
104.79
83.78
59.18
47.61
% Of Sales
-
4.71%
4.97%
4.78%
4.94%
4.32%
3.90%
3.73%
3.56%
3.12%
2.98%
Employee Cost
-
787.40
735.88
695.98
625.58
566.70
497.99
391.79
335.49
266.28
211.63
% Of Sales
-
21.02%
22.59%
22.05%
21.82%
18.02%
15.17%
13.96%
14.24%
14.03%
13.27%
Manufacturing Exp.
-
374.26
366.91
404.52
387.75
439.11
415.69
331.73
275.82
238.31
220.23
% Of Sales
-
9.99%
11.26%
12.82%
13.52%
13.96%
12.67%
11.82%
11.71%
12.56%
13.81%
General & Admin Exp.
-
271.85
268.52
246.68
245.42
246.73
255.40
205.02
178.12
139.13
75.19
% Of Sales
-
7.26%
8.24%
7.82%
8.56%
7.85%
7.78%
7.31%
7.56%
7.33%
4.71%
Selling & Distn. Exp.
-
324.77
277.62
280.74
223.67
245.00
231.18
212.94
196.09
169.91
151.78
% Of Sales
-
8.67%
8.52%
8.89%
7.80%
7.79%
7.04%
7.59%
8.32%
8.95%
9.51%
Miscellaneous Exp.
-
42.30
26.59
22.45
66.29
28.85
78.56
66.97
58.26
4.73
151.78
% Of Sales
-
1.13%
0.82%
0.71%
2.31%
0.92%
2.39%
2.39%
2.47%
0.25%
0.95%
EBITDA
-
678.27
441.98
415.42
273.69
514.07
711.98
537.60
427.49
339.83
302.08
EBITDA Margin
-
18.11%
13.57%
13.16%
9.55%
16.35%
21.69%
19.16%
18.15%
17.91%
18.94%
Other Income
-
74.66
58.08
54.76
40.77
58.69
51.97
39.88
48.34
89.00
43.85
Interest
-
22.24
27.57
26.91
34.56
32.13
30.23
36.48
44.39
32.35
32.93
Depreciation
-
182.42
177.73
172.95
163.26
179.55
103.13
86.73
67.13
55.79
46.74
PBT
-
548.27
294.76
270.32
116.64
361.08
630.59
454.27
364.31
340.69
266.26
Tax
-
104.24
51.11
67.52
20.44
101.93
152.39
129.94
88.11
78.38
62.72
Tax Rate
-
19.01%
17.34%
24.98%
17.52%
28.23%
24.17%
28.60%
24.19%
23.01%
23.56%
PAT
-
447.39
243.65
202.80
96.20
259.15
478.20
324.33
276.20
262.39
203.74
PAT before Minority Interest
-
444.03
243.65
202.80
96.20
259.15
478.20
324.33
276.20
262.31
203.54
Minority Interest
-
3.36
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.08
0.20
PAT Margin
-
11.94%
7.48%
6.43%
3.36%
8.24%
14.57%
11.56%
11.72%
13.83%
12.77%
PAT Growth
-
83.62%
20.14%
110.81%
-62.88%
-45.81%
47.44%
17.43%
5.26%
28.79%
 
Unadjusted EPS
-
35.01
18.97
15.42
7.38
20.15
37.92
25.65
21.98
20.96
16.44

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Shareholder's Funds
3,122.39
2,688.57
2,455.26
2,259.19
2,208.43
1,959.66
1,553.78
1,254.01
1,051.59
864.89
Share Capital
25.27
25.24
25.24
25.24
25.24
25.24
25.24
25.17
25.14
25.04
Total Reserves
3,097.12
2,663.01
2,430.02
2,233.95
2,183.19
1,934.42
1,528.54
1,228.70
1,025.97
837.95
Non-Current Liabilities
313.40
419.42
548.32
662.57
699.57
459.45
509.52
433.15
282.35
533.82
Secured Loans
133.94
234.01
347.22
433.63
447.65
292.12
366.21
330.18
194.62
364.08
Unsecured Loans
6.91
0.00
4.52
50.64
55.56
1.88
0.00
0.00
0.00
90.43
Long Term Provisions
25.28
25.88
24.55
20.22
18.03
14.93
12.21
8.72
5.34
0.00
Current Liabilities
1,097.50
1,007.57
955.93
969.95
904.36
791.45
633.65
640.17
578.53
215.49
Trade Payables
524.32
423.47
396.54
421.11
306.59
340.99
268.37
234.52
178.55
119.61
Other Current Liabilities
274.74
266.75
316.41
297.50
236.44
250.88
166.00
175.33
99.97
64.63
Short Term Borrowings
209.69
239.04
177.30
184.85
325.35
143.94
157.14
201.36
263.35
0.00
Short Term Provisions
88.75
78.31
65.68
66.49
35.98
55.64
42.14
28.96
36.66
31.25
Total Liabilities
4,548.83
4,115.56
3,959.51
3,891.71
3,812.36
3,210.56
2,696.95
2,327.33
1,911.81
1,613.62
Net Block
1,940.38
1,952.96
1,983.27
2,014.18
1,800.43
1,353.59
1,104.23
944.08
699.22
637.85
Gross Block
2,632.86
2,464.33
2,318.22
2,176.95
2,546.33
1,932.05
1,579.07
1,338.55
988.42
881.17
Accumulated Depreciation
692.48
511.37
334.95
162.77
745.90
578.46
474.84
394.47
289.20
243.32
Non Current Assets
2,171.08
2,170.08
2,217.69
2,269.79
2,198.38
1,609.14
1,299.78
1,117.30
875.01
708.52
Capital Work in Progress
66.33
73.00
94.64
128.74
267.22
164.90
129.17
94.51
94.75
38.28
Non Current Investment
30.05
17.52
22.24
25.82
16.19
9.00
8.87
33.93
40.68
32.39
Long Term Loans & Adv.
126.82
115.83
103.58
78.44
103.47
71.26
47.49
37.12
37.07
0.00
Other Non Current Assets
7.50
10.77
13.96
22.61
11.07
10.39
10.02
7.66
3.29
0.00
Current Assets
2,377.75
1,945.48
1,741.82
1,621.92
1,613.98
1,601.42
1,397.17
1,210.03
1,036.80
905.10
Current Investments
90.38
69.35
113.57
0.00
0.00
0.15
0.15
0.15
0.15
0.15
Inventories
1,072.50
880.59
882.22
837.42
926.56
847.58
741.03
669.89
466.40
380.23
Sundry Debtors
681.51
602.27
500.16
445.87
353.00
449.79
417.81
344.88
367.21
388.02
Cash & Bank
282.30
150.57
35.85
175.54
124.79
76.01
58.24
12.16
10.36
10.79
Other Current Assets
251.06
228.26
194.46
145.78
209.63
227.89
179.94
182.95
192.68
125.91
Short Term Loans & Adv.
31.44
14.44
15.56
17.31
36.19
53.84
31.22
27.73
56.71
125.91
Net Current Assets
1,280.25
937.91
785.89
651.97
709.62
809.97
763.52
569.86
458.27
689.61
Total Assets
4,548.83
4,115.56
3,959.51
3,891.71
3,812.36
3,210.56
2,696.95
2,327.33
1,911.81
1,613.62

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Cash From Operating Activity
492.28
341.13
281.91
708.65
455.29
522.29
388.77
353.84
214.20
191.45
PBT
546.46
290.53
262.06
116.64
361.08
630.59
454.27
364.31
340.69
266.26
Adjustment
178.61
188.13
174.86
211.11
187.91
139.92
126.16
156.99
39.13
70.45
Changes in Working Capital
-121.97
-80.06
-103.73
410.30
-18.68
-117.72
-100.10
-87.39
-101.25
-98.42
Cash after chg. in Working capital
603.10
398.60
333.19
738.05
530.31
652.79
480.33
433.91
278.57
238.29
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-110.82
-57.47
-51.28
-29.40
-75.02
-130.50
-91.56
-80.07
-64.37
-45.86
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-0.98
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-156.31
-135.40
-148.82
-218.33
-676.40
-369.01
-259.87
-285.90
-198.10
-117.39
Net Fixed Assets
-46.98
-60.09
-105.61
466.60
-716.66
-362.17
-275.00
-298.69
-163.58
-136.07
Net Investments
-106.61
-4.05
-114.15
-15.57
-52.96
-6.96
20.86
6.14
0.48
7.61
Others
-2.72
-71.26
70.94
-669.36
93.22
0.12
-5.73
6.65
-35.00
11.07
Cash from Financing Activity
-183.20
-130.41
-159.13
-461.51
250.54
-136.13
-82.93
-71.81
-17.75
-74.01
Net Cash Inflow / Outflow
152.77
75.32
-26.04
28.81
29.43
17.15
45.97
-3.87
-1.65
0.05
Opening Cash & Equivalents
218.15
142.83
168.87
140.06
74.25
56.69
10.72
9.14
10.79
10.74
Closing Cash & Equivalent
370.92
218.15
142.83
168.87
103.68
74.25
56.69
10.72
9.14
10.79

Financial Ratios

Consolidated /

Standalone
Description
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Book Value (Rs.)
247.12
213.02
194.55
179.02
174.99
155.28
123.12
99.63
83.62
68.93
ROA
10.25%
6.03%
5.17%
2.50%
7.38%
16.19%
12.91%
13.03%
14.88%
13.23%
ROE
15.28%
9.47%
8.60%
4.31%
12.43%
27.22%
23.10%
23.97%
27.41%
27.29%
ROCE
16.53%
9.94%
9.44%
4.82%
13.78%
27.92%
24.38%
23.78%
25.72%
24.83%
Fixed Asset Turnover
1.48
1.37
1.43
1.23
1.42
1.89
1.95
2.04
2.05
1.94
Receivable days
62.09
61.27
53.75
50.16
46.12
47.78
49.05
54.65
72.06
82.43
Inventory Days
94.47
97.98
97.70
110.76
101.93
87.49
90.74
87.21
80.79
77.81
Payable days
51.02
50.35
52.23
52.92
39.11
36.45
31.30
30.47
25.50
19.75
Cash Conversion Cycle
105.54
108.90
99.22
108.00
108.95
98.82
108.49
111.38
127.35
140.48
Total Debt/Equity
0.15
0.23
0.29
0.38
0.42
0.31
0.40
0.48
0.50
0.53
Interest Cover
25.65
11.69
11.05
4.38
12.24
21.86
13.45
9.21
11.53
9.09

Annual Reports:

FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013
FY 2012
FY 2011
FY 2010

News Update:


  • USFDA completes inspection at Ipca Laboratories’ Piparia unit
    26th Aug 2019, 09:17 AM

    At the conclusion of the inspection, USFDA issued a Form 483 with 3 observations

    Read More
  • Ipca Laboratories - Quarterly Results
    13th Aug 2019, 12:53 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.